# MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas

> **NCT02311582** · PHASE1,PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 55 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **BIOLOGICAL:** MK-3475
- **DEVICE:** MRI-guided laser ablation

## Key facts

- **NCT ID:** NCT02311582
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-05
- **Primary completion:** 2024-04-15
- **Final completion:** 2024-04-15
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2025-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311582, "MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02311582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*